Daily non-political popular news in brief.

Glucose levels trigger compensation for type 2 diabetics

Many individuals with type 2 diabetes are diabetic because their body no longer responds to the hormone insulin. Before they become clinically diabetic their body tries to compensate for the lack of insulin responsiveness by increasing the mass of insulin-secreting cells (beta cells) in the pancreas. A new study shows that in mice with high-fat diet-induced insulin resistance, changes in glucose concentration are likely to be the main trigger of increased beta-cell mass.

Read more »

Keywords: glucose, levels, trigger, compensation, type, diabetics, level, diabetic

« Previous | Next »

Similar news on "Glucose levels trigger compensation for type 2 diabetics":

1. JCI table of contents: January 2, 2007
   01-02-2007 · EurekAlert!
   This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published January 2, 2007, in the JCI, including: Genetic mutation alters response to heart failure drugs; Glucose levels trigger compensation for type 2 diabetics; Cell relocation fixes damage to the gut lining; BCL2 reins in BIM, preventing leukemic cell death; and Complex macrophage and monocyte interactions at work in atherosclerosis.
   Similar news · Read more »
   
2. Protein power: Researchers trigger insulin production in diabetic mice
   01-08-2008 · EurekAlert!
   University of Florida researchers have coaxed liver and pancreatic cells within diabetic mice into churning out insulin by injecting the animals with a naturally occurring protein called Pdx1, opening up a new research avenue that someday could lead to safer treatments for type 1 diabetes. Pdx1 activates the genes controlling the development of the pancreas cells that make and release insulin to maintain safe levels of glucose in the body.
   Similar news · Read more »
   
3. Low dose of serotonin-acting chemical improves blood sugar tolerance
   11-06-2007 · EurekAlert!
   An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press. Importantly, the researchers found, those effects of the drug occurred at a low dose that had no influence on feeding behavior, body weight, activity level, or energy expenditure.
   Similar news · Read more »
   
4. Immunosuppressive drugs are a double-edged sword to type 1 diabetics
   09-04-2007 · EurekAlert!
   Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
   Similar news · Read more »
   
5. Researchers identify a role for glucose-sensing neurons in type 2 diabetes
   08-29-2007 · EurekAlert!
   In cases of Type 2 diabetes, the body's cells fail to appropriately regulate blood glucose levels. Research led by scientists at Beth Israel Deaconess Medical Center and Oregon Health & Science University describes a previously unrecognized role for glucose-sensing neurons in the onset of the disease demonstrating that an important component of Type 2 diabetes may indeed be "in your head."
   Similar news · Read more »
   
6. JCI table of contents: Oct. 12, 2006
   10-12-2006 · EurekAlert!
   This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Oct. 12, 2006, in the JCI, including: Waste not, want not: Role for caveolin-3 in muscular dystrophy; Elevated PTTG1 levels trigger mitotic mischief, causing thyroid cancer; NF-kappaB2 teaches tolerance; and Type I IFNs beat IFN-gamma to the immunoproteasome.
   Similar news · Read more »
   
7. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
   06-04-2007 · EurekAlert!
   Nutrition 21 Inc. today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
   Similar news · Read more »
   
8. VBI research offers potential route to diabetes therapeutics
   01-22-2007 · EurekAlert!
   Work at Virginia Bioinformatics Institute is providing important information for researchers designing drugs for type 2 diabetics by helping researchers to identify potential targets for docking inhibitors that will slow down, but not fully eliminate, the body's overproduction of glucose.
   Similar news · Read more »
   
9. Research says sugar coated proteins seal in a memory of diabetes
   06-28-2007 · EurekAlert!
   Researchers at the University of Warwick's Warwick Medical School have uncovered a process that locks the body's metabolism in a diabetic state after only relatively limited exposure to high glucose levels.
   Similar news · Read more »
   
10. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
    09-19-2007 · EurekAlert!
    New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes, further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
    Similar news · Read more »